The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $2.00

Today's change+0.11 +5.82%
Updated December 18 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $2.00

Today's change+0.11 +5.82%
Updated December 18 4:00 PM -5GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc crosses above 20-day moving average

Neptune Technologies & Bioressources Inc closed up sharply Thursday, rallying (U.S.)$0.11 or 5.82% to (U.S.)$2.00 and crossing above its 20-day moving average. Over the last five days, shares have gained 1.01%, but are down 31.03% for the last year to date. Shares have underperformed the S&P 500 by 50.75% during the last year.

Key company metrics

  • Open(U.S.) $1.91
  • Previous close(U.S.) $1.89
  • High(U.S.) $2.01
  • Low(U.S.) $1.90
  • Bid / Ask(U.S.) $1.48 / (U.S.) $1.99
  • YTD % change-31.03%
  • Volume152,775
  • Average volume (10-day)105,995
  • Average volume (1-month)126,315
  • Average volume (3-month)156,042
  • 52-week range(U.S.) $1.11 to (U.S.) $3.61
  • Beta1.17
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.37
Updated December 18 4:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-215.57%

Neptune Technologies & Bioressources Inc has a net profit margin of -215.57%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedAug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014Nov 30, 201311/30/2013
Revenue3444
Total other revenue--------
Total revenue3444
Gross profit-4111
Total cost of revenue7334
Total operating expense1712514
Selling / general / administrative78109
Research & development3222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----10
Other operating expenses, total0-2-110
Operating income-14-8-1-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-4-1-10
Income after tax-15-4-1-10
Income tax, total0000
Net income-13-50-9
Total adjustments to net income--------
Net income before extra. items-13-50-9
Minority interest2022
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-50-9
Inc. avail. to common incl. extra. items-13-50-9
Diluted net income-13-50-9
Dilution adjustment0000
Diluted weighted average shares75736161
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.060.00-0.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.17-0.060.03-0.14